IP Library › Granted Patent US 11,253,380
Granted Patent B2
US 11,253,380 · App. 16/474,226 · Granted Feb 22, 2022

Absorbable stent

Inventors: Wenjiao Lin (Shenzhen, CN); Wenchao Fu (Shenzhen, CN)
Assignee: Biotyx Medical (Shenzhen) Co., Ltd
A61F2/915A61F2/82A61F2002/91541A61F2002/91575A61F2002/91591A61F2210/0004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,253,380
App. No.
16/474,226
Granted
Feb 22, 2022
Kind
B2
Abstract

An absorbable stent includes an absorbable matrix. The matrix includes a number of wave-shaped rings connected by connection units and arranged in an axial direction. The wave-shaped ring includes a number of waves arranged in a circumferential direction. A peak, a valley and a support connecting the peak and the valley form the wave. Two adjacent wave-shaped rings and the connection unit form a closed side supporting unit. The matrix has a volume of [4, 40] μm per unit blood vessel area. The absorbable stent has sufficient radial supporting strength for clinical applications. Moreover, the volume of the matrix per unit blood vessel area is less than volumes of existing stents. When the absorbable stent and existing stents are made of the same material, the absorbable stent has a shorter degradation and absorption cycle.

Claims (18)

1. An absorbable stent, comprising: an absorbable matrix, the matrix comprising a plurality of wave-shaped rings arrayed axially; two adjacent wave-shaped rings in the plurality of wave-shaped rings are connected by a connection unit; each wave-shaped ring comprises a plurality of circumferentially arrayed waves; each wave comprises a peak, a valley, and a supporting strut connecting the peak with the valley; two adjacent wave-shaped rings in the plurality of wave-shaped rings and the connection units form a closed side branch unit; and the absorbable matrix volume per unit vascular area is in the range of 4 μm to 40 μm;

wherein, when the matrix is expanded to a rated diameter, an included angle α of the supporting struts is in the range of 70 degrees to 100 degrees;

wherein a ratio of a strut width to a wall thickness of each supporting strut is in the range of 1 to 2;

wherein, when the rated diameter of the matrix is in the range of 1 mm to 5 mm the section length L of each supporting strut is in the range of 0.5 mm to 0.8 mm and the matrix volume per unit vascular area is in the range of 4 μm to 13 μm;

wherein, when the rated diameter of the matrix is in the range of 5 mm to 15 mm the section length L of each supporting strut is in the range of 0.9 mm to 2.0 mm and the matrix volume per unit vascular area is in the range of 8 μm to 25 μm;

wherein, when the rated diameter of the matrix is in the range of 15 mm to 40 mm the section length L of each supporting strut is in the range of 1.8 mm to 8 mm and the matrix volume per unit vascular area is in the range of 11 μm to 40 μm; and

wherein a fillet is formed on the supporting strut, in cross-section of the supporting strut.

2. The absorbable stent according to claim 1 , wherein the ratio of a strut width to a wall thickness of each supporting strut is in the range of 1.45 to 1.8.

3. The absorbable stent according to claim 1 , wherein when the rated diameter of the matrix is in the range of 1 mm to 5 mm, the matrix volume per unit vascular area is in the range of 4 μm to 7.5 μm.

4. The absorbable stent according to claim 1 , wherein when the rated diameter of the matrix is in the range of 5 mm to 15 mm, the matrix volume per unit vascular area is in the range of 8 μm to 15 μm.

5. The absorbable stent according to claim 1 , wherein when the rated diameter of the matrix is in the range of 15 mm to 40 mm, the matrix volume per unit vascular area is in the range of 11 μm to 26 μm.

6. The absorbable stent according to claim 1 , wherein a wall thickness of the matrix is in the range of 0.02 mm to 0.30 mm.

7. The absorbable stent according to claim 6 , wherein when the rated diameter of the matrix is in the range of 1 mm to 5 mm, the wall thickness of the matrix is in the range of 0.03 mm to 0.12 mm.

8. The absorbable stent according to claim 6 , wherein when the rated diameter of the matrix is in the range of 5 mm to 15 mm, the wall thickness of the matrix is in the range of 0.06 mm to 0.20 mm.

9. The absorbable stent according to claim 6 , wherein when the rated diameter of the matrix is in the range of 15 mm to 40 mm, the wall thickness of the matrix is in the range of 0.13 mm to 0.26 mm.

10. The absorbable stent according to claim 1 , wherein a radial supporting strength of the absorbable stent is not less than 55 kPa.

11. The absorbable stent according to claim 1 , wherein the matrix is made of nitride iron.

12. The absorbable stent according to claim 1 , wherein the connection unit is one of: a dot shape, a strut shape, an S shape, a Q shape, and an n shape.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2020
From: LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD
To: BIOTYX MEDICAL (SHENZHEN) CO., LTD
Reel/Frame 051423/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2019
From: LIN, WENJIAO; FU, WENCHAO
To: LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD
Reel/Frame 049611/0021 →
Priority Claims (1)
CN 201611271031.6 · Dec 31, 2016 · national
Continuity (1)
Related Publication 20200206004A1 · Jul 2, 2020
Cited By (3)
US 1,100,200 US 1,127,206 US 1,136,196